(VIANEWS) - The Herzfeld Caribbean Basin Fund (CUBA), Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP), Goldman Sachs MLP Energy Renaissance Fund (GER) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | The Herzfeld Caribbean Basin Fund (CUBA) | 4.75 | -2.26% | 22.29% | 2022-06-07 20:23:16 |
| 2 | Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP) | 5.42 | -1.45% | 8.62% | 2022-06-01 15:13:07 |
| 3 | Goldman Sachs MLP Energy Renaissance Fund (GER) | 13.37 | -0.22% | 5.7% | 2022-06-03 05:23:15 |
| 4 | PetMed Express (PETS) | 20.87 | -2.66% | 5.66% | 2022-06-10 15:46:13 |
| 5 | Bristol (BMY) | 73.46 | -2.17% | 3.2% | 2022-06-13 14:52:30 |
| 6 | Jerash Holdings (JRSH) | 6.38 | -2.15% | 3.04% | 2022-05-29 13:15:06 |
| 7 | Equity Residential (EQR) | 69.13 | -4.32% | 2.86% | 2022-06-13 14:54:12 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. The Herzfeld Caribbean Basin Fund (CUBA) - Dividend Yield: 22.29%
Thomas J. Herzfeld Advisors, Inc. launched the Herzfeld Caribbean Basin Fund Inc., a closed-ended equity mutual funds. Herzfeld/Cuba manages the fund. The fund invests on the United States' public equity markets. Fund employs fundamental analysis to invest in stock of companies likely to profit from technological, economic and structural developments in countries within the Caribbean Basin. This includes Cuba, Jamaica and Trinidad and Tobago. The fund invests in stock of diverse companies. Herzfeld Caribbean Basin Fund Inc., which was established March 10, 1992, is based in the United States.
Volume
Today's last reported volume for The Herzfeld Caribbean Basin Fund is 14368, 38.28% below its average volume of 23279.
The Herzfeld Caribbean Basin Fund's last close was $4.75, 24.44% under its 52-week high of $6.29.
The Herzfeld Caribbean Basin Fund's Revenue
Year-on-year quarterly revenue growth grew by 417.5%, now sitting on 1.26M for the twelve trailing months.
The Herzfeld Caribbean Basin Fund's Stock Yearly Top and Bottom Value
The Herzfeld Caribbean Basin Fund's stock is valued at $4.75 at 03:15 EST, way under its 52-week high of $6.29 and above its 52-week low of $4.49.
The Herzfeld Caribbean Basin Fund's Moving Average
The Herzfeld Caribbean Basin Fund's value is below its 50-day moving average of $4.95 and way below its 200-day moving average of $5.36.More news about The Herzfeld Caribbean Basin Fund.
2. Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP) - Dividend Yield: 8.62%
Alpine Global Premier Properties Fund, a closed-end equity mutual funds, was launched by Alpine Woods Capital Investors, LLC. The fund invests in public equity markets around the world. It invests in stock of real estate companies. The fund invests in companies that have value stocks. To create its portfolio, the fund combines fundamental analysis with top down and bottom up stock picking approaches. The fund benchmarks its performance against the FTSE EPRA/NAREIT Global TR Index and MSCI US REIT Gross Total Return Index. Alpine Global Premier Properties Fund was established on February 13, 2007, and is based in the United States.
Volume
Today's last reported volume for Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund is 370130, 25.94% below its average volume of 499787.
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's last close was $5.50, 20.52% below its 52-week high of $6.92.
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's Revenue
Year-on-year quarterly revenue growth grew by 27.4%, now sitting on 18.56M for the twelve trailing months.
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's Stock Yearly Top and Bottom Value
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's stock is valued at $5.42 at 03:15 EST, way below its 52-week high of $6.92 and above its 52-week low of $4.98.
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's Moving Average
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund's value is under its 50-day moving average of $5.81 and way below its 200-day moving average of $6.24.More news about Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund.
3. Goldman Sachs MLP Energy Renaissance Fund (GER) - Dividend Yield: 5.7%
Goldman Sachs MLP & Energy Renaissance Fund are closed-ended equity mutual funds that were launched by Goldman Sachs Asset Management L.P. This fund invests in the United States' public equity markets. The fund invests in stock of energy companies. This fund invests primarily in Master Limited Partnerships (and related energy companies) that are growing stocks. It focuses on investments in midstream MLPs. To create its portfolio, it combines fundamental and quantitative analysis with top-down stock selection. It benchmarks its portfolio performance against the Alerian MLP Index Total Return. Goldman Sachs MLP, Energy Renaissance Fund was established on September 26, 2014. It is based in the United States.
Volume
Today's last reported volume for Goldman Sachs MLP Energy Renaissance Fund is 50652, 30.59% below its average volume of 72976.
Goldman Sachs MLP Energy Renaissance Fund's last close was $13.37, 1.84% below its 52-week high of $13.62.
Goldman Sachs MLP Energy Renaissance Fund's Stock Yearly Top and Bottom Value
Goldman Sachs MLP Energy Renaissance Fund's stock is valued at $13.37 at 03:15 EST, below its 52-week high of $13.62 and way higher than its 52-week low of $9.58.
Goldman Sachs MLP Energy Renaissance Fund's Moving Average
Goldman Sachs MLP Energy Renaissance Fund's value is above its 50-day moving average of $12.53 and way higher than its 200-day moving average of $11.43.More news about Goldman Sachs MLP Energy Renaissance Fund.
4. PetMed Express (PETS) - Dividend Yield: 5.66%
PetMed Express, Inc., and its affiliates, do business under the name 1-800-PetMeds, operate as an American pet pharmacy. It sells prescription and non-prescription medications for pets, as well as other products that are beneficial to horses, dogs, and cats. The company sells non-prescription medication and supplies such as flea, tick, joint and bone care products, vitamins and nutritional supplements, hygiene and products. It also offers prescription medications including heartworm and tick prevention, allergy, asthma, treatment for dermatitis and pain medications. It also offers pet food, including beds, crates and stairs. The company sells products via its website, mobile app, telephone contact center, direct mail/print through brochures, catalogs and postcards. PetMed Express, Inc., was established in Delray Beach, Florida in 1996.
Volume
Today's last reported volume for PetMed Express is 497273, 25.85% above its average volume of 395123.
PetMed Express's last close was $21.44, 41.66% below its 52-week high of $36.75.
The company's growth estimates for the present quarter is 18.2% and a drop 3.2% for the next.PetMed Express's Revenue
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 279.09M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,PetMed Express's stock is considered to be overbought (>=80).
PetMed Express's Stock Yearly Top and Bottom Value
PetMed Express's stock is valued at $20.87 at 03:15 EST, way below its 52-week high of $36.75 and higher than its 52-week low of $19.09.
PetMed Express's Moving Average
PetMed Express's worth is below its 50-day moving average of $22.84 and way below its 200-day moving average of $25.94.More news about PetMed Express.
5. Bristol (BMY) - Dividend Yield: 3.2%
The Bristol-Myers Squibb Company develops and licenses products for biopharmaceutical use. It markets, distributes, sells, and markets them worldwide. The company offers therapeutic products in the following therapeutic categories: oncology and immunology, hematology, cardiology, vascular, and hematology. Opdivo is a biologic product that can be used to treat anti-cancer indications. Eliquis, an oral inhibitor, targets stroke prevention in adults with non-valvular arrhythmia and prevents and treats venous thromboembolic diseases. Orencia, a bioproduct for active RA patients and patients suffering from prostate-specific antibodies, reduces symptoms and signs in children with juvenile idiopathic arthritis. Sprycel is a tyrosine kinase inhibitor for treatment Philadelphia chromosome positive chronic myeloidleukemia. Yervoy is a monoclonal anti-cancer antibody that can be used to treat patients with metastatic or unresectable melanoma. Empliciti, a humanized monoclonal antibodies for treatment of multiple myeloma, and Baraclude, which acts as an oral antiviral for chronic hepatitis B. It also offers Reyataz as a protease inhibit for treatment of the human immunodeficiencyvirus (HIV); Sustiva, a non nucleoside reverse transcriptase inhibitor for treatment of HIV; Daklinza NS5A replica complex inhibitor, Sunvepra NS3 protease inhibitor and Beclabuvir NS5B antagonist. The company sells its products to hospitals, wholesalers and retail pharmacies as well as the medical profession. Pfizer, Otsuka, Nektar, GRYT Health, Ubiquigent Limited, NeoImmuneTech, Inc., and Astrazeneca Plc are some of the company's collaboration partners. The original name of the company was Bristol-Myers Company. In 1989, it changed its name from Bristol-Myers Squibb Company to Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is located in New York, New York. It was established in 1887.
Volume
Today's last reported volume for Bristol is 10956200, 27.47% below its average volume of 15106600.
Bristol's last close was $73.58, 5.49% higher than its 52-week high of $69.75.
Bristol's Sales
Bristol's sales growth is 12.5% for the present quarter and 9.4% for the next. The company's growth estimates for the present quarter and the next is 19% and 27.4%, respectively.
Bristol's Revenue
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 44.38B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Bristol's stock is considered to be overbought (>=80).
Bristol's Stock Yearly Top and Bottom Value
Bristol's stock is valued at $73.46 at 03:15 EST, higher than its 52-week high of $69.75.
Bristol's Moving Average
Bristol's worth is way higher than its 50-day moving average of $57.79 and way higher than its 200-day moving average of $63.26.More news about Bristol.
6. Jerash Holdings (JRSH) - Dividend Yield: 3.04%
Jerash Holdings, Inc., via its subsidiaries, produces and exports custom-made and ready-made sportswear and outerwear. It offers jackets and polo shirts as well as pants and shorts in knitted material. The company serves numerous brand-name retailers across the United States and Jordan as well as internationally. Fairfield, New Jersey is the home of this company.
Volume
Today's last reported volume for Jerash Holdings is 12070, 51.09% below its average volume of 24679.
Jerash Holdings's last close was $6.38, 30.65% under its 52-week high of $9.20.
Jerash Holdings's Sales
Jerash Holdings's sales growth is 26.9% for the current quarter and 33% for the next. The company's growth estimates for the ongoing quarter is 16.7% and a drop 11.8% for the next.
Jerash Holdings's Revenue
Year-on-year quarterly revenue growth grew by 78.2%, now sitting on 136.17M for the twelve trailing months.
Jerash Holdings's Stock Yearly Top and Bottom Value
Jerash Holdings's stock is valued at $6.38 at 03:15 EST, way below its 52-week high of $9.20 and way higher than its 52-week low of $5.30.
Jerash Holdings's Moving Average
Jerash Holdings's worth is above its 50-day moving average of $6.12 and under its 200-day moving average of $6.79.More news about Jerash Holdings.
7. Equity Residential (EQR) - Dividend Yield: 2.86%
Equity Residential believes in creating communities that are healthy and happy. Equity Residential, a S&P 500 member, focuses on the development, acquisition and management of apartment rentals in high-density urban areas and suburban neighborhoods where renters today want to live and work. Equity Residential has invested in or owns 306 properties that include 79,065 apartments. These units are located throughout New York, Boston, Washington, D.C. Seattle, San Francisco and San Francisco.
Volume
Today's last reported volume for Equity Residential is 1341060, 19.92% below its average volume of 1674710.
Equity Residential's last close was $69.33, 21.3% under its 52-week high of $88.09.
The company's growth estimates for the current quarter is 54.2% and a drop 47.1% for the next.Equity Residential's Revenue
Year-on-year quarterly revenue growth declined by 8.5%, now sitting on 2.43B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Equity Residential's stock is considered to be overbought (>=80).
Equity Residential's Stock Yearly Top and Bottom Value
Equity Residential's stock is valued at $69.13 at 03:15 EST, way below its 52-week high of $88.09 and way higher than its 52-week low of $56.08.
Equity Residential's Moving Average
Equity Residential's worth is way below its 50-day moving average of $85.40 and way under its 200-day moving average of $80.08.More news about Equity Residential.